{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:23:12Z","timestamp":1742966592491,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071601709"},{"type":"electronic","value":"9781071601716"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0171-6_8","type":"book-chapter","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T17:03:08Z","timestamp":1578330188000},"page":"117-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["3D-3-Culture: Tumor Models to Study Heterotypic Interactions in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Sofia P.","family":"Rebelo","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Tatiana R.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Paula Marques","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Brito","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL et al (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32:40\u201351. https:\/\/doi.org\/10.1038\/nbt.2786","journal-title":"Nat Biotechnol"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","volume":"87","author":"BA Ruggeri","year":"2014","unstructured":"Ruggeri BA, Camp F, Miknyoczki S (2014) Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem Pharmacol 87:150\u2013161. https:\/\/doi.org\/10.1016\/j.bcp.2013.06.020","journal-title":"Biochem Pharmacol"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/biot.201300492","volume":"9","author":"J Hickman","year":"2014","unstructured":"Hickman J, Graeser R, de Hoogt R et al (2014) Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro\/ex vivo. Biotechnol J 9:1115\u20131128. https:\/\/doi.org\/10.1002\/biot.201300492","journal-title":"Biotechnol J"},{"key":"8_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201600505","volume":"12","author":"VE Santo","year":"2017","unstructured":"Santo VE, Rebelo SP, Estrada MF et al (2017) Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs. Biotechnol J 12:1600505. https:\/\/doi.org\/10.1002\/biot.201600505","journal-title":"Biotechnol J"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17:1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004","journal-title":"Neoplasia"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.addr.2014.05.003","volume":"79","author":"C Hirt","year":"2014","unstructured":"Hirt C, Papadimitropoulos A, Mele V et al (2014) \u201cIn vitro\u201d 3D models of tumor-immune system interaction. Adv Drug Deliv Rev 79:145\u2013154. https:\/\/doi.org\/10.1016\/j.addr.2014.05.003","journal-title":"Adv Drug Deliv Rev"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.drudis.2016.04.010","volume":"21","author":"A Nyga","year":"2016","unstructured":"Nyga A, Neves J, Stamati K et al (2016) The next level of 3D tumour models: immunocompetence. Drug Discov Today 21:1421\u20131428. https:\/\/doi.org\/10.1016\/j.drudis.2016.04.010","journal-title":"Drug Discov Today"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.addr.2014.06.004","volume":"79\u201380","author":"M Alemany","year":"2014","unstructured":"Alemany M, Semino CE (2014) Bioengineering 3D environments for cancer models. Adv Drug Deliv Rev 79\u201380:40\u201349. https:\/\/doi.org\/10.1016\/j.addr.2014.06.004","journal-title":"Adv Drug Deliv Rev"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jbiotec.2016.01.031","volume":"221","author":"VE Santo","year":"2016","unstructured":"Santo VE, Estrada MF, Rebelo SP et al (2016) Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models. J Biotechnol 221:118\u2013129. https:\/\/doi.org\/10.1016\/j.jbiotec.2016.01.031","journal-title":"J Biotechnol"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/J.MATTOD.2015.05.002","volume":"18","author":"W Asghar","year":"2015","unstructured":"Asghar W, El Assal R, Shafiee H et al (2015) Engineering cancer microenvironments for in vitro 3-D tumor models. Mater Today 18:539\u2013553. https:\/\/doi.org\/10.1016\/J.MATTOD.2015.05.002","journal-title":"Mater Today"},{"key":"8_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep28951","volume":"6","author":"K Stock","year":"2016","unstructured":"Stock K, Estrada MF, Vidic S et al (2016) Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep 6:28951. https:\/\/doi.org\/10.1038\/srep28951","journal-title":"Sci Rep"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biomaterials.2015.11.030","volume":"78","author":"MF Estrada","year":"2015","unstructured":"Estrada MF, Rebelo SP, Davies EJ et al (2015) Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression. Biomaterials 78:50\u201361. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.11.030","journal-title":"Biomaterials"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu Y-X (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","journal-title":"Nat Immunol"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","volume":"267","author":"A Sica","year":"2008","unstructured":"Sica A, Allavena P, Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267:204\u2013215. https:\/\/doi.org\/10.1016\/j.canlet.2008.03.028","journal-title":"Cancer Lett"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065\u20131073. https:\/\/doi.org\/10.1189\/jlb.0609385","journal-title":"J Leukoc Biol"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, Schmidt SV, Sander J et al (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274\u2013288. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.006","journal-title":"Immunity"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/bjc.2017.356","volume":"117","author":"S Aras","year":"2017","unstructured":"Aras S, Raza Zaidi M (2017) TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer 117:1583\u20131591. https:\/\/doi.org\/10.1038\/bjc.2017.356","journal-title":"Br J Cancer"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin Y, Kobayashi S, Leader A et al (2017) Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169:750\u2013765.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.04.014","journal-title":"Cell"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/med.21338","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y (2015) Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev 35:408\u2013436. https:\/\/doi.org\/10.1002\/med.21338","journal-title":"Med Res Rev"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/0008-5472.CAN-13-1816","volume":"74","author":"S Mok","year":"2014","unstructured":"Mok S, Koya RC, Tsui C et al (2014) Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res 74:153\u2013161. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1816","journal-title":"Cancer Res"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545:495\u2013499. https:\/\/doi.org\/10.1038\/nature22396","journal-title":"Nature"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biomaterials.2018.02.030","volume":"163","author":"SP Rebelo","year":"2018","unstructured":"Rebelo SP, Pinto C, Martins TR et al (2018) 3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment. Biomaterials 163:185\u2013197. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.02.030","journal-title":"Biomaterials"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1476-4598-9-168","volume":"9","author":"S Haubeiss","year":"2010","unstructured":"Haubeiss S, Schmid JO, M\u00fcrdter TE et al (2010) Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer 9:168. https:\/\/doi.org\/10.1186\/1476-4598-9-168","journal-title":"Mol Cancer"},{"issue":"1","key":"8_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/carcin\/bgn232","volume":"30","author":"S Madar","year":"2009","unstructured":"Madar S, Brosh R, Buganim Y, Ezra O, Goldstein I, Solomon H, Kogan I, Goldfinger N, Klocker H, Rotter V (2009) Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 30(1):20\u201327. https:\/\/doi.org\/10.1093\/carcin\/bgn232","journal-title":"Carcinogenesis"},{"issue":"4","key":"8_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124283","volume":"10","author":"A Rudisch","year":"2015","unstructured":"Rudisch A, Dewhurst MR, Horga LG, Kramer N, Harrer N, Dong M, van der Kuip H, Wernitznig A, Bernthaler A, Dolznig H, Sommergruber W (2015) High EMT signature score of invasive non-small cell lung cancer (NSCLC) cells correlates with NF\u03baB driven colony-stimulating factor 2 (CSF2\/GM-CSF) secretion by neighboring stromal fibroblasts. PLoS One 10(4):e0124283. https:\/\/doi.org\/10.1371\/journal.pone.0124283","journal-title":"PLoS One"}],"container-title":["Methods in Pharmacology and Toxicology","Immuno-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0171-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T01:28:35Z","timestamp":1604971715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0171-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071601709","9781071601716"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0171-6_8","relation":{},"ISSN":["1557-2153","1940-6053"],"issn-type":[{"type":"print","value":"1557-2153"},{"type":"electronic","value":"1940-6053"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}